| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 3,443,000 | | Cost of Revenue | 1,024,000 | | | Gross Profit | 2,419,000 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 1,115,000 | | Non Recurring | 61,000 | | Others | 186,000 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 1,057,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14,000 | | Earnings Before Interest And Taxes | 1,010,000 | | Interest Expense | 256,000 | | Income Before Tax | 754,000 | | Income Tax Expense | 352,000 | | Minority Interest | (128,000) | | | | Net Income From Continuing Ops | 274,000 | | | Non-recurring Events | | Discontinued Operations | 43,000 | | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 317,000 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $317,000 |
|
0.29% Nasdaq 
0.10 (0.31%) 
Income Statement
